Mecillinam: A Possible Alternative Option for Non-Complicated Urinary Tract Infections Treatment Caused by Enterobacterales

Mafalda Felgueiras; Valquíria Alves

doi:10.20344/amp.19385

Mecillinam: A Possible Alternative Option for Non-Complicated Urinary Tract Infections Treatment Caused by Enterobacterales

Authors

Mafalda Felgueiras Secção de Microbiologia. Serviço de Patologia Clínica. Unidade Local de Saúde de Matosinhos. Porto. https://orcid.org/0000-0001-5632-8580
Valquíria Alves Secção de Microbiologia. Serviço de Patologia Clínica. Unidade Local de Saúde de Matosinhos. Porto.

DOI:

https://doi.org/10.20344/amp.19385

Keywords:

Amdinocillin/therapeutic use, Enterobacteriaceae Infections/drug therapy, Urinary Tract Infections/drug therapy

Abstract

N/a.

Downloads

References

Fruchs F, Ahmadzada A, Plambeck L, Wille T, Hamprecht A. Susceptibility of clinical enterobacterales isolates with common and rare carbapenemases to mecillinam. Front Microbiol. 2021;11:627267. DOI: https://doi.org/10.3389/fmicb.2020.627267

Jansaker F, Frimodt-Moller N, Bjerrum L, Knudsen JD. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a rondomized, double-blinded, placebo-controlled clinical trial study protocol. BMC Infect Dis. 2016;16:727. DOI: https://doi.org/10.1186/s12879-016-2022-0

Jansaker F, Frimodt-Moller N, Benfield TL, Knudsen JD. Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: literature review. Infect Drug Resist. 2018,11:761-71. DOI: https://doi.org/10.2147/IDR.S163280

Frimodt-Moller N. Mecillinam – reversion of resistance and how to test it. EBioMedicine. 2017;23:4-5. DOI: https://doi.org/10.1016/j.ebiom.2017.08.023

Direção-Geral da Saúde. Norma n.º 015/2011 - terapêutica de infeções do aparelho urinário (comunidade). Lisboa: DGS; 2011. [cited 2022 Oct 05]. Available from: https://normas.dgs.min-saude.pt/2011/08/30/terapeutica-de-infecoes-do-aparelho-urinario-comunidade/.

Downloads

Published

2023-07-11

How to Cite

Felgueiras M, Alves V. Mecillinam: A Possible Alternative Option for Non-Complicated Urinary Tract Infections Treatment Caused by Enterobacterales. Acta Med Port [Internet]. 2023 Jul. 11 [cited 2025 Apr. 6];36(9):607-8. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19385

Download Citation

Issue

Vol. 36 No. 9 (2023): September

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.